Game-changing donation to fight glaucoma
The largest, single philanthropic investment in vision science in Australia to prevent blindness from glaucoma brings hope to millions.
Staff reporters2 min read
Advertisement
The largest, single philanthropic investment in vision science in Australia to prevent blindness from glaucoma brings hope to millions.
A US health agency is committing up to NZ$217.41m to develop the first-ever vision-restoring eye transplant.
EssilorLuxottica has signed an agreement to acquire Espansione Group, the Italian manufacturer of Meibomask, a low-level light therapy (LLLT) device, and OPE (optimal power energy) intense pulsed light device, for patients with meibomian gland dysfunction, blepharitis or Sjögren syndrome and other c
Chemistry researchers at Canada’s University of Waterloo have developed a 3D-printed hydrogel for continuous drug delivery via contact lenses (CLs).
Medix21 is bringing New World Medical’s Streamline Surgical System, a novel dual-action device to manage intraocular hypertension and the progression of open angle glaucoma, to New Zealand.
The BLINK2 study found the benefits of wearing high-add power multifocal CLs for controlling myopia progression continue even after the lenses are no longer used.
The diagnosis of mild traumatic brain injury (TBI) could be enhanced by using a combination of visual assessments and machine-learning approaches, according to US researchers. Writing in Jama Oph
Australian researchers found nocturnal hypoxia may be an “under-appreciated important modifiable risk factor for neovascular age-related macular degeneration (nAMD)”.
The latest research commissioned by Macular Degeneration New Zealand (MDNZ) shows that awareness of AMD in people over the age of 50 has dropped from 60% in 2020 to 55% in 2024.
Researchers in Taiwan found reduced gut microbial diversity may be associated with retinopathy of prematurity (ROP) development in high-risk preterm infants. Writing in Clinical & Experimental Opht
American Brokeback Mountain actor Jake Gyllenhaal described being legally blind as occasionally advantageous in his career. Despite his childhood amblyopia having naturally resolved, the 44-year-old has to wear corrective lenses for his 6/60 vision.
Researchers in Australia have found glucose-monitoring contact lenses (CLs) offer a pain-free and convenient alternative to finger-prick blood testing, which could improve treatment adherence and long-term health outcomes in diabetic patients living in remote areas.